At 36 years old, Anthony Andrews has struggled with health problems for most of his adult life. Currently on dialysis for kidney failure, Andrews also has a complex family history of heart disease, as well as vascular issues. As a result, Andrews has had no options for a life-saving intervention should a cardiac emergency occur – until now.
In November 2012, he became the first person in New England to receive a new type of heart defibrillator, or ICD, approved by the U.S. Food and Drug Administration just two months ago.
The cardiac device, called a subcutaneous implantable defibrillator (S-ICD), is implanted under the skin and delivers an electric shock to the heart to treat an abnormally rapid heartbeat. Unlike a traditional ICD, which involves one or more insulated wires that run from the device through a patient’s vein to the lower chamber of the heart, the S-ICD does not require access to a patient’s heart or blood vessels.